None listed
Conditions
Interventions
None listed
Sponsors
INDOGENIX BIOSCIENCES LLP
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with chronic pain more than 3 months in only single region will be taken. 2.Patients diagnosed with electromyography having trigger zone areas. 3.Patients with chronic pain but unresponsive to conservative medications. 4. Patients who gave willing consent for trial.
Exclusion criteria
Exclusion criteria: 1.Patients with pain in more than one region. 2.Patients who are allergic to CBD oil. 3.Patients having infections at the pain region. 4.Patients with history of abuse of cannabis. 5.Patients with sever psychiatric illness. 6.Patients who refuse to participate. 7.Patients having cardiac issues. 8.Pregnancy and lactating women. 9.Drug abuse or addictions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study the topical application of cannabryl oil in myofascial pain of head neck and shoulder regions at nerve innervation zones along with any side effects and efficacy.Timepoint: Base line- pain assessed 2 weeks - pain relief and side effects. 4 weeks - pain relief and side effects. 8 weeks - pain relief and side effects. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To see for allergic reactions. 2. To see any systemic side effects from usage of cannabryl oil.Timepoint: 1. Allergic reactions -15 days 2. Systemic side effects -30 days. | — |
Countries
India
Contacts
Public ContactDr Nimisha Verma
IMS , BHU
Outcome results
None listed